Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma
Open Access
- 7 April 2005
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 115 (3) , 359-367
Abstract
Pancreatic ductal adenocarcinoma is among the top 10 causes of death from cancer in industrialized countries. In comparison with other gastrointestinal malignancies, pancreatic cancer is one of the tumors most resistant to chemotherapy. An important mechanism of tumor multidrug resistance is increased drug efflux mediated by several transporters of the ABC superfamily. Especially BCRP (ABCG2), MDR1 P‐glycoprotein (ABCB1) and members of the MRP (ABCC) family are important in mediating drug resistance. The MRP family consists of 9 members (MRP1–MRP9) with MRP1–MRP6 being best characterized with respect to protein localization and substrate selectivity. Here, we quantified the mRNA expression of BCRP and of all MRP family members in normal human pancreas and pancreatic carcinoma and analyzed the mRNA level of the transporters most abundantly expressed in pancreatic tissue, BCRP, MRP1, MRP3, MRP4 and MRP5, in 37 tissue samples. In addition, we determined the localization of the 4 MRP proteins in normal human pancreas and in pancreatic carcinoma. The expression of BCRP, MRP1 and MRP4 mRNA did not correlate with tumor stage or grading. On the other hand, the expression of MRP3 mRNA was upregulated in pancreatic carcinoma samples and was correlated with tumor grading. The MRP5 mRNA level was significantly higher in pancreatic carcinoma tissue compared to normal pancreatic tissue. These data suggest that MRP3 and MRP5 are involved in drug resistance of pancreatic tumors and that quantitative analysis of their expression may contribute to predict the benefit of chemotherapy in patients with pancreatic cancer.Keywords
This publication has 54 references indexed in Scilit:
- Adjuvant therapy in pancreatic cancer: historical and current perspectivesAnnals of Oncology, 2003
- Estimates of cancer incidence and mortality in Europe in 1995European Journal of Cancer, 2002
- Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicatorsJournal of Gastrointestinal Surgery, 2000
- Relationship between hospital volume and late survival after pancreaticoduodenectomySurgery, 1999
- Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database11No competing interests declared.Journal of the American College of Surgeons, 1999
- Recurrence after resection for ductal adenocarcinoma of the pancreasWorld Journal of Surgery, 1997
- Trends in pancreatic cancer mortality in Europe, 1955–1989International Journal of Cancer, 1994
- Patterns of failure after curative resection of pancreatic carcinomaCancer, 1990
- Radical pancreatectomy for ductal cell carcinoma of the head of the pancreasCancer, 1989
- Cancer of the pancreas: 50 years of surgeryCancer, 1987